Stay informed with the latest litigation news. Explore now

Biogen Ma competitive analysis

Latest publications and patents of Biogen Ma New

Explore the latest publications and patents granted to Biogen Ma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 4, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Biogen Ma

Aug 27, 2025Implantable Intraventricular Sampling And Infusion Access DeviceGranted And Under Opposition
Aug 20, 2025Glycogen Synthase Kinase 3 Inhibitors And Uses ThereofPending
Aug 6, 2025Methods For Treating Alzheimer'S DiseasePending
Aug 6, 2025Condensed Pyridazine Or Pyrimidine As Btk InhibitorsGranted
Jul 23, 2025Microtubule Destabilizer Additives To Increase Recombinant Viral Vector TitersPending
Jul 16, 2025Fluid Catheter Device For Recording Brain StateGranted And Under Opposition
Jul 9, 2025Methods Of Treating Inflammatory And Autoimmune Diseases With NatalizumabPending
Jun 11, 2025Assay For Jc Virus AntibodiesPending
Jun 4, 2025Compounds For Treating Huntington'S DiseasePending
May 28, 2025Emopamil-Binding Protein Inhibitors And Uses ThereofPending

Explore Biogen Ma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent1
Apr 3, 2024Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters1
Jan 24, 2024Optimized Factor Viii Gene1
Nov 22, 2023Methods Of Treating Or Preventing Spinal Muscular Atrophy5
Oct 18, 2023A Limiter For A Dispensing Device2
Apr 26, 2023Use Of Raman Spectroscopy To Monitor Culture Medium2
Dec 14, 2022Assay For Jc Virus Antibodies1
Nov 30, 2022Method Of Assessing Risk Of Pml2
Aug 24, 2022Compositions And Uses For Treating Multiple Sclerosis14
Aug 10, 2022Methods For Overcoming Glutamine Deprivation During Mammalian Cell Culture1

Latest PTAB cases involving Biogen Ma New

Discover the latest PTAB cases involving Biogen Ma, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 10, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Biogen Ma

PGR2022-00054Jul 29, 2022SANDOZBIOGEN MAInstitution Denied
IPR2019-00789Mar 5, 2019SAWAI USABIOGEN MATerminated
IPR2018-01403Jul 13, 2018MYLAN PHARMACEUTICALSBIOGEN MATerminated
IPR2016-00916Apr 18, 2016SWISS PHARMABIOGEN MAInstitution Denied
IPR2016-00915Apr 18, 2016SWISS PHARMABIOGEN MAInstitution Denied
IPR2016-00912Apr 18, 2016SWISS PHARMABIOGEN MAInstitution Denied
IPR2015-01136May 1, 2015COALITION FOR AFFORDABLE DRUGS VBIOGEN MAInstitution Denied

Top competitors of Biogen Ma

Top competitors of Biogen Ma based on patent oppositions.